Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Faulkner

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of Antimicrobial Chemotherapy|September 1, 1996
Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study GroupF Colardyn, K L Faulkner
The Pediatric Infectious Disease Journal|August 1, 1996
Efficacy, safety and tolerability of meropenem as empiric antibiotic therapy in hospitalized pediatric patientsJ S Bradley, K L Faulkner, K P Klaugman
The Journal of Antimicrobial Chemotherapy|July 1, 1995
Safety profile of meropenem: international clinical experience based on the first 3125 patients treated with meropenemS R Norrby, P A Newell, K L Faulkner, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1995
A compilation of meropenem tissue distribution dataM Hutchison, K L Faulkner, P J Turner, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of Antimicrobial Chemotherapy|September 1, 1996
Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study GroupF Colardyn, K L Faulkner
The Pediatric Infectious Disease Journal|August 1, 1996
Efficacy, safety and tolerability of meropenem as empiric antibiotic therapy in hospitalized pediatric patientsJ S Bradley, K L Faulkner, K P Klaugman
The Journal of Antimicrobial Chemotherapy|July 1, 1995
Safety profile of meropenem: international clinical experience based on the first 3125 patients treated with meropenemS R Norrby, P A Newell, K L Faulkner, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1995
A compilation of meropenem tissue distribution dataM Hutchison, K L Faulkner, P J Turner, et al.
Pageof 1